Organogenesis Holdings Inc. (ORGO)
$1.29+0.78%Close
SELLCRISIS · day 45
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $166M
- Beta
- 1.29
- P/E (TTM)
- -1.63
- Short % float
- 26.15%
- Days to cover
- 26.6
- SI change
- +6.3%
- 1W
- -3.01%
- 1M
- -15.69%
- vs SPY 1W
- -4.17%
- vs SPY 1M
- -18.68%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ORGO?
- LOPJLB’s latest quantitative signal on Organogenesis Holdings Inc. (ORGO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ORGO in?
- Organogenesis Holdings Inc. (ORGO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Organogenesis Holdings Inc. (ORGO) do?
- Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings desig…